Document:

<PAGE>

                                                                   Exhibit 10.63

                                   AGREEMENT
                                   ---------

     THIS AGREEMENT (the "Agreement") is made October 25, 2001 (the "Effective
                          ---------                                  ---------
Date") by and between ALAN P. COHEN ("Cohen") and ANDRX CORPORATION ("Company").
----                                  -----                           -------

                                   RECITALS
                                   --------

     WHEREAS, Cohen has been an employee of the Company since its inception; and

     WHEREAS, Cohen has served as the Company's Chief Executive Officer ("CEO")
                                                                          ---
and Co-Chairman of the Board of Directors (the "Board");
                                                -----

     WHEREAS, Cohen wishes to retire from his position as CEO, as President of
Anda, Inc., and as an officer and director of each of the Company's other direct
and indirect subsidiaries, but he and the Company desire that he continue on the
Board, with the honorary title of Co-Chairman; and

     WHEREAS, the parties wish to set forth all obligations liabilities and
confirm all understandings between them pursuant to or arising out of Cohen's
retirement as CEO and Cohen's continuing responsibilities and services as a
member of the Board, or any other obligations between the parties.

                                   AGREEMENT
                                   ---------

     NOW THEREFORE, in consideration of the premises and mutual covenants set
forth herein, it is hereby agreed as follows:

     1.   Recitals.  The foregoing recitals are true and correct in all respects
          --------
and are incorporated herein by reference.

     2.   General.
          -------

          (a)  The Company and Cohen agree that due to Cohen's retirement as CEO
and as President of Anda, Inc., his employment with the Company and any
subsidiaries is hereby terminated, effective as of the Effective Date.

          (b)  The Company agrees to use its best efforts to remove Cohen as the
Company's representative or contact from the records of all applicable
governmental agencies and regulatory authorities including, but not limited to,
the Food and Drug Administration, the Internal Revenue Service, and the
Department of Revenue.  The Company agrees to also use its best efforts to
remove Cohen from all of the Company's federal, state and local licenses on a
timely basis if permitted by amendment or if not upon renewal of all such
licenses. The Company agrees to use its best efforts to provide Cohen evidence
of the undertakings set forth in this paragraph (b) within thirty (30) days of
the date first written above.

     3.   Stock Options. The Company and Cohen agree that, notwithstanding the
          -------------
termination of Cohen's employment with the Company, all Stock Option Agreements
and grants thereunder by and between Cohen and the Company shall remain in full
force and effect and shall continue to vest according
<PAGE>

to their vesting scheduling while Cohen continues to serve as a member of the
Board just as though he had remained an employee of the Company.

     4.   Co-Chairman of the Board of Directors.  Cohen agrees to continue
          -------------------------------------
serving as the Co-Chairman of the Board of Directors of the Company.  Cohen
acknowledges that while he remains a member of the Board of Directors of the
Company, he has fiduciary obligations to the Company and such other duties as
generally apply to directors, including the duty of care and loyalty. Cohen
agrees that for a period of two (2) years after his retirement as CEO or one (1)
year after the date he ceases to be a member of the Company's Board, whichever
is later, he will not directly or indirectly, whether individually or through
any form of entity, engage in the business of distributing generic
pharmaceutical products manufactured by third parties to pharmacies or physician
offices.  Cohen further agrees that for a period of two (2) years after his
retirement as CEO or one (1) year after the date he ceases to be a member of the
Company's Board, whichever is earlier (the "Termination Date"), he will not
directly or indirectly, whether individually or through any form of entity, (i)
solicit or otherwise obtain business from any pharmacy customers of the Company
for generic products which are intended to compete with the generic products
that the Company was selling, actively in the process of developing (as
evidenced by written records), gain FDA approval to market or was in the process
of acquiring (as evidenced by written records) on the Effective Date, or (ii)
solicit, market or otherwise motivate physicians to prescribe pharmaceuticals
which are intended to compete with the brand products (whether approved by FDA
as an ANDA or an NDA) that the Company was selling, attempting to develop, gain
FDA approval to market, or was in the process of acquiring (as evidenced by
written records) on the Effective Date.  Notwithstanding the foregoing, (w)
Cohen shall not be prohibited from providing samples to physicians of products
that he is otherwise permitted to sell pursuant to this Agreement, (x) the term
"process of acquiring" shall only include acquisitions that the Company is
considering acquiring if the Company takes actual steps to achieve such
acquisition from the seller thereof within 30 days of the Effective Date, (y)
after the Company commences the sale of its first internally developed brand
product or April 2, 2002, whichever is earlier, Cohen shall be permitted,
notwithstanding his continued service on the Board, to solicit, market or
otherwise motivate physicians to prescribe pharmaceuticals, and to sell such
pharmaceuticals to pharmacies, which are intended to compete with the Company's
cough and cold and pain product lines, and (z) within 30 days of the Effective
Date, the Company shall notify Cohen, in writing, of the products that it
believes are included in the restrictions described in sub-parts (i) and (ii)
above. While Cohen remains on the Board, he shall disclose any conflicts of
interest that might arise by the Company later commencing any operations that
would cause his personal endeavors to be in conflict with the Company, such as
those described in the preceding sentence, and shall remove himself from all
such discussions and votes.

     5.   Director and Officer Insurance Policies.  The Company agrees to
          ---------------------------------------
maintain all Director and Officer Insurance Policies (the "D & O Policies") and
                                                           --------------
the applicable limits in existence at the time of this Agreement.  The Company
further agrees to maintain tail coverage pertaining to the D & O Policies
covering past actions by Cohen for a period of five (5) years subsequent to the
Effective Date, or the date Cohen ceases to be the Co-Chairman, whichever is
later.

     6.   Indemnification Agreements.  The Company agrees to maintain in full
          --------------------------
force and effect all indemnification agreements in existence as of the Effective
Date as they relate to Directors and Officers of the Company ("Indemnification
                                                               ---------------
Agreements").  The Indemnification Agreements shall remain in effect without any
----------
limitation as to time.

                                       2
<PAGE>

     7.   Duty to Provide Information.  The Company agrees to immediately inform
          ---------------------------
Cohen, after being informed itself, of any actions, claims, demands,
investigations, lawsuits, proceedings and formal or informal inquiries by any
regulating authorities brought against the Company, arising out of any alleged
actions of Cohen occurring during any period of time in which Cohen served the
Company in any capacity.

     8.   Cooperation with Actions, Investigations, etc.
          ---------------------------------------------

          Cohen agrees to assist the Company, as is reasonably necessary, in its
defense or prosecution of any legal action or suit, formal or informal inquiry
by any regulatory body which is currently existing or commenced in the future
and based on facts or subjects of which Cohen has knowledge.  Cohen shall make
himself reasonably available, for information requests and consultation
regarding business affairs and transactions of the Company occurring or
commenced during Cohen's employment by the Company in connection with the
prosecution or defense of any actions, claims, demands or proceedings filed
against the Company, or to cooperate with any investigation or formal or
informal inquiry by any regulating authorities governing the activities of the
Company.  This provision shall not require Cohen to serve as an expert in any
manner, but only as a fact witness connection with providing testimony.

     9.   Right to Hire Counsel.  Cohen shall have the right to hire counsel of
          ---------------------
his choosing, at the Company's cost, for representation in connection with any
and all assistance all actions previously described in paragraph 8.

     10.  The Company's Property.  In connection with Cohen's retirement, Cohen
          ----------------------
shall return all the Company's property including credit cards and portable
communication devices within ten (10) days of the execution of this Agreement
which shall not be used by Cohen as the Co-Chairman.  The Company's property
shall not include the items enumerated in Exhibit "A" to this Agreement.
                                          -----------

     11.  Right to Hire Certain Employees.  Cohen agrees that for a period of
          -------------------------------
two (2) years after his retirement or one (1) year after he ceases to be a
member of the Board, whichever is later, Cohen shall not, either directly or
indirectly, for his own account or either as agent, servant or employee or as
shareholder of any corporation, or member of any firm, engage, hire, employ or
solicit the employment of any person who, at the time of termination of Cohen's
employment, was an employee of the Company or its subsidiaries whose duties
required such employee to be familiar with the operation of the business of the
Company or its subsidiaries.  Notwithstanding the foregoing, at any time, Cohen
shall be entitled to hire Athena Melfi or such other persons  agreed to by the
Company, as evidenced by a written document signed by an officer of the Company.

     12.  Confidential Information.  Cohen's rolodex, all of its contents,
          ------------------------
including telephone number and addresses to be taken by him from the Company
shall not be deemed confidential information or trade secrets of the Company.
All such other information proposed to be taken by Cohen, if any, including his
personal files, shall first be determined solely by the Company whether or not
such information is confidential information or trade secrets before they are
taken by Cohen.  Cohen agrees not to remove any information deemed by the
Company to be confidential information.

     13.  Notices.  All notices, requests, consents and other communications
          -------
required or permitted under this Agreement shall be in writing (including
electronic transmission) and shall be (as elected by the person giving such
notice) hand delivered by messenger or courier service (including overnight mail

                                       3
<PAGE>

service), electronically transmitted, or mailed (airmail if international) by
registered or certified mail (postage prepaid), return receipt requested,
addressed to:

                                        With a copy to:
     Alan P. Cohen                      Richard B. Comiter, Esq.
     3320 Fairfield Lane                Comiter & Singer
     Weston, Florida 33331              3801 PGA Blvd., Suite 802
     Facsimile: (954) 389-5691          Palm Beach Gardens, Florida
                                        Facsimile (561) 626-4742

     Andrx Corporation
     4955 Orange Drive
     Ft. Lauderdale, Florida 33314
     Facsimile: (954) 585-1723
     Attn: Scott Lodin, Esq.

or to such other address as any party may designate by notice complying with the
terms of this Section.  Each such notice shall be deemed delivered (a) on the
date delivered, if by personal delivery or courier; (b) on the date of
transmission with confirmation of receipt, if by electronic transmission; and
(c) on the date three (3) business days following the deposit of the notice in a
U.S. Mail depository (or, if applicable, in an appropriate airmail deposition),
properly addressed and with necessary postage.

     14.  Arbitration.  Notwithstanding anything to the contrary in this
          -----------
Agreement, the parties irrevocably agree that all claims for monetary damages
and disputes relating in any way to the performance, interpretation, validity or
breach of this Agreement shall be referred to final and binding arbitration,
before a single arbitrator, under the Florida Arbitration Code. The arbitrator
shall be selected by the parties, but if the parties are unable to reach
agreement on selection of the arbitrator within thirty (30) days after the date
on which the notice of arbitration is sent to the parties to the arbitration,
then either party may petition the circuit court within Broward County, Florida
and each party may submit up to three arbitrators to the court for the court's
consideration.  The court's selection of an arbitrator shall be final and non-
appealable.  In no event shall a party be entitled to punitive, treble or
special damages, or injunctive relief in any arbitration or judicial proceeding
and all parties hereby waive their rights to any punitive, treble or special
damages, or injunctive relief.  In the event an arbitration panel or a court
concludes that the punitive, treble or special damages, or injunctive relief
waiver contained in the previous sentence is unenforceable, then the parties
agree that the court with subject matter jurisdiction over the confirmation of
the award shall have sole and exclusive jurisdiction to determine issues of
entitlement and amount of punitive, treble or special damages, or injunctive
relief.  The arbitrator shall not have subject matter jurisdiction to decide any
issues relating to the statute of limitations or to any request for injunctive
relief, and the parties hereby stipulate to stay the arbitration proceeding
(without the need of a bond) until any such issues in dispute are resolved.
Judgment upon the award rendered by the arbitrator shall be final, binding and
conclusive upon the parties and their respective administrators, executors,
legal representatives, heirs, successors and permitted assigns, and may be
entered in any court of competent jurisdiction. All questions as to the meaning
of the provisions of this paragraph, or as to the arbitrability of any dispute
under this paragraph shall be resolved by the arbitrator, shall be absolutely
binding, and not subject to judicial review. The costs and expenses of
arbitration shall be borne ultimately as the arbitrator directs but each party
shall pay the costs and expenses of its own counsel and of any witnesses and
evidence presented by such party.

                                       4
<PAGE>

     15.  Jurisdiction and Venue.  Any arbitration, civil action or legal
          ----------------------
proceeding arising out of or relating to this Agreement shall be brought in the
courts of record in Broward County, Florida.  Each party irrevocably consents to
the personal jurisdiction of such court in any such arbitration, civil action or
legal proceeding and waives any objection to the laying of venue of any such
arbitration, civil action or legal proceeding in such court. Service of any
court paper may be effected on such party by any method for notice, as provided
in this Agreement, or in such other manner as may be provided under applicable
laws, rules of procedure or local rules.

     16.  Counterparts.  This Agreement may be signed in two counterparts which
          ------------
together shall constitute an original instrument.

     17.  Severability.  Any term or provision of this Agreement that is invalid
          ------------
or unenforceable in any situation in any jurisdiction shall not effect the
validity or enforceability of the remaining terms and provisions hereof or the
validity or enforceability of the offending term or provision in any other
situation or in any other jurisdiction.

     18.  Entire Agreement.  This Agreement, including the exhibits referred to
          ----------------
herein and which form a part of this Agreement, sets forth all obligations
liabilities and understandings between the parties to the other pursuant to or
arising out of Cohen's retirement as the Chief Executive Officer and continued
responsibilities to the Company, and supersedes all prior and contemporaneous
agreements understandings, inducements or conditions, express or implied, oral
or written, except as herein contained.

     IN WITNESS WHEREOF, Cohen and the Company have caused this Agreement to be
executed and delivered as of the Effective Date.

                                      Andrx Corporation

/s/ Alan P. Cohen                     By: /s/ Scott Lodin
----------------------------             ------------------------------
Alan P. Cohen                         Scott Lodin
                                      Executive Vice President & General Counsel

                                       5<PAGE>

Exhibit (4.1)

                  SECOND SUPPLEMENTAL INDENTURE (the "Supplement"), dated as of
August 21, 2001, between Valassis Communications, Inc., a Delaware corporation
(the "Company"), and The Bank of New York, a New York banking corporation, as
trustee (the "Trustee").

                               W I T N E S S E T H
                               - - - - - - - - - -

                  WHEREAS, the Company and the Trustee have executed and
delivered the Indenture, dated as of November 15, 1994, as amended on January 6,
2000 (the "Indenture"), providing for the issuance thereunder by the Company,
and the authentication and delivery by the Trustee, of the Company's 9.55%
Senior Notes due 2003 (the "Notes");

                  WHEREAS, Section 1102 of the Indenture authorizes the Company
and the Trustee, with the consent of the holders of not less than a majority in
aggregate principal amount of the Notes, to amend, from time-to-time, the
Indenture by supplemental indenture for the purposes therein set forth;

                  WHEREAS, the holders of not less than a majority in aggregate
principal amount of the Notes have consented to the amendments to the Indenture
set forth herein and the Company, by appropriate corporate action, has
determined to supplement the Indenture in the manner described below, and all
acts or proceedings necessary to authorize and constitute this Supplement a
valid and binding agreement in accordance with the terms hereof, have been done
and taken.

                  NOW, THEREFORE, in consideration of the premises herein, the
Company covenants and agrees with the Trustee, for the equal and proportionate
benefit of the respective holders of the Notes from time-to-time, as follows:

                  Section 1.        Indenture Supplement.
                                    --------------------

                  (a) Section 301 of the Indenture shall be amended by deleting
Section 301(15) which reads "if the Debt Securities of the series shall be
subject to defeasance pursuant to either or both of Sections 403 and 404" and
replacing it with "Intentionally omitted."

                  (b) Section 403 of the Indenture shall be amended to delete
the following clause from the beginning of Section 403:

                  "If this Section 403 is specified in the manner contemplated
by Section 301 to be applicable to Debt Securities of any series,"

                  (c)      Section 404 of the Indenture shall be amended to
delete the following clause from the beginning of Section 404:

                  "If this Section 404 is specified in the manner contemplated
by Section 301 to be applicable to Debt Securities of any series."

<PAGE>

                  Section 2.   Indenture to Remain in Effect.  The Indenture, as
                               -----------------------------
amended and supplemented by this Supplement, shall remain in full force and
effect.

                  Section 3.   GOVERNING LAW. THIS SUPPLEMENT SHALL BE GOVERNED
                               -------------
BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, WITHOUT
REGARD TO CONFLICTS OF LAWS PRINCIPLES THEREOF.

                  Section 4.   Counterparts.  This Supplement may be executed in
                               ------------
one or more counterparts, each of which shall be an original, but such
counterparts together shall constitute one and the same instrument.

                  IN WITNESS WHEREOF, the parties hereto have caused this Second
Supplemental Indenture to be duly executed as of the day and year first above
written.

ATTEST:                                    VALASSIS COMMUNICATIONS, INC.

/s/ Sandra Robinson                        By: /s/Barry P. Hoffman
----------------------------------             --------------------------------
                                               Name:Barry P. Hoffman
                                               Title: Executive Vice President

                                                      [Seal]

ATTEST:                                    THE BANK OF NEW YORK

/s/ Robert Massimillo                      By: /s/ Mary LaGumina
----------------------------------             --------------------------------
                                               Name: Mary LaGumina
                                               Title: Vice President

                                                      [Seal]

                                       2

<PAGE>

STATE OF                            )
         ---------------------------)       SS.:
COUNTY OF                           )
         ---------------------------

                  On the ____ day of _____________________, 2001, before me
personally came __________________________, to me known, who, being by me duly
sworn, did depose and say that he is ___________________ of Valassis
Communications, Inc., one of the corporations described in and which executed
the foregoing instrument; that he knows the seal of said corporation; that the
seal affixed to said instrument is such corporate seal; that it was so affixed
by authority of the Board of Directors of said corporation, and that he signed
his name thereto by like authority.

                                                  ______________________________
                                                                 Notary Public

                                                      Qualified in
                                                      Commission Expires

[Seal]

<PAGE>

STATE OF NEW YORK  )
                   )       ss.:
COUNTY OF NEW YORK )

                  On the ______ day of ____________, 2001, before me personally
came ______________________, to me known, who, being by me duly sworn, did
depose and say that (s)he is ______________________ of The Bank of New York, one
of the corporations described in and which executed the foregoing instrument;
that (s)he knows the seal of said corporation; that the seal affixed to said
instrument is such corporate seal; and that it was so affixed by authority of
the Board of Directors of said corporation, and that (s)he signed his/her name
thereto by like authority.

                                               _________________________________
                                                                   Notary Public

                                                  Qualified in
                                                  Commission Expires
[Seal]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00031-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00031-of-00352.parquet"}]]